242 filings
Page 2 of 13
8-K
2h0cp fm01diszj8
2 May 23
CytoSorbents Reports First Quarter 2023 Results
5:27pm
8-K
zlq8jo3t7 jlt4f3
26 Apr 23
Other Events
4:31pm
8-K
ieeahmiw1g9nok
20 Apr 23
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
7:30am
8-K
rb3abeqz9r8c 8xr9h
6 Apr 23
Entry into a Material Definitive Agreement
4:21pm
8-K
8w7mz
9 Mar 23
CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
5:20pm
8-K
nn9tbtd nr9p87z
31 Jan 23
CytoSorbents Issues Stockholder Letter and Reports Preliminary
7:42pm
8-K
mumci86 djrr
29 Dec 22
CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement
4:32pm
8-K
aozwv
16 Nov 22
CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled
4:55pm
8-K
yk3006w0csv4bd qxzl7
3 Nov 22
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results
5:23pm
8-K
bsj9tjd4nmw5b
6 Oct 22
CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch
5:07pm
8-K
jkbx9fu
27 Sep 22
CytoSorbents Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey
6:40pm
8-K
1eizfse48xj
15 Aug 22
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7:45am
8-K
gpmzvq9m
2 Aug 22
CytoSorbents Reports Second Quarter 2022 Financial and Operational Results
4:19pm
8-K
icjx 7zmv43wzw1oracg
8 Jun 22
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
3pdtk2fld3
3 Jun 22
CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries
4:15pm
8-K
5qd7wokt27l
31 May 22
Other Events
5:48pm
8-K
y6xej0 esjhh
3 May 22
CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
7:04pm
8-K
9peafe zfug9mc
29 Apr 22
Other Events
4:31pm
8-K
gt1pa0v mnp7wg
28 Apr 22
CytoSorbents Highlights the Strategy of “Enhanced Lung Rest” Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress
5:00pm
8-K
7czwk16
14 Apr 22
CytoSorbents To Expand Direct Sales of CytoSorb® to the United Kingdom, the Sixth Largest Medical Device Market in the World
4:15pm